Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis
- PMID: 32604935
- PMCID: PMC7355646
- DOI: 10.3390/jcm9062013
Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis
Erratum in
-
Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013.J Clin Med. 2022 May 27;11(11):3016. doi: 10.3390/jcm11113016. J Clin Med. 2022. PMID: 35683636 Free PMC article.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is one of the major causes of end-stage renal disease (ESRD) in childhood and is mostly associated with focal segmental glomerulosclerosis (FSGS). More than 50 monogenic causes of SRNS or FSGS have been identified. Recently, the mutation detection rate in pediatric patients with SRNS has been reported to be approximately 30%. In this study, genotype-phenotype correlations in a cohort of 291 Korean pediatric patients with SRNS/FSGS were analyzed. The overall mutation detection rate was 43.6% (127 of 291 patients). WT1 was the most common causative gene (23.6%), followed by COQ6 (9.4%), NPHS1 (8.7%), NUP107 (7.1%), and COQ8B (6.3%). Mutations in COQ6, NUP107, and COQ8B were more frequently detected, and mutations in NPHS2 were less commonly detected in this cohort than in study cohorts from Western countries. The mutation detection rate was higher in patients with congenital onset, those who presented with proteinuria or chronic kidney disease/ESRD, and those who did not receive steroid treatment. Genetic diagnosis in patients with SRNS provides not only definitive diagnosis but also valuable information for decisions on treatment policy and prediction of prognosis. Therefore, further genotype-phenotype correlation studies are required.
Keywords: focal segmental glomerulosclerosis; genetic analysis; steroid-resistant nephrotic syndrome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Bierzynska A., McCarthy H.J., Soderquest K., Sen E.S., Colby E., Ding W.Y., Nabhan M.M., Kerecuk L., Hegde S., Hughes D., et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 2017;91:937–947. doi: 10.1016/j.kint.2016.10.013. - DOI - PubMed
-
- Trautmann A., Bodria M., Ozaltin F., Gheisari A., Melk A., Azocar M., Anarat A., Caliskan S., Emma F., Gellermann J., et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: The PodoNet registry cohort. Clin. J. Am. Soc. Nephrol. 2015;10:592–600. doi: 10.2215/CJN.06260614. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous